Menu
GeneBe

FOXF1

forkhead box F1, the group of Forkhead boxes

Basic information

Region (hg38): 16:86510526-86515422

Previous symbols: [ "FKHL5" ]

Links

ENSG00000103241NCBI:2294OMIM:601089HGNC:3809Uniprot:Q12946AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • alveolar capillary dysplasia with misalignment of pulmonary veins (Definitive), mode of inheritance: AD
  • alveolar capillary dysplasia with misalignment of pulmonary veins (Supportive), mode of inheritance: AD
  • alveolar capillary dysplasia with misalignment of pulmonary veins (Strong), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Alveolar capillary dysplasia with misalignment of pulmonary veinsADCardiovascularThe condition can involve congenital cardiac anomalies, and awareness may allow early managementCardiovascular; Genitourinary; Gastrointestinal; Musculoskeletal; Pulmonary15520767; 19500772; 20425831; 22990143; 23407133; 23444129; 23505205; 24842713

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the FOXF1 gene.

  • not provided (48 variants)
  • Alveolar capillary dysplasia with pulmonary venous misalignment (44 variants)
  • Inborn genetic diseases (16 variants)
  • FOXF1-related condition (3 variants)
  • not specified (2 variants)
  • VATER association (1 variants)
  • Abnormal cardiac atrium morphology (1 variants)
  • Atresia of urethra;Fetal megacystis;Ventricular septal defect (1 variants)
  • See cases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the FOXF1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
10
clinvar
5
clinvar
16
missense
2
clinvar
7
clinvar
25
clinvar
4
clinvar
3
clinvar
41
nonsense
5
clinvar
5
start loss
0
frameshift
9
clinvar
3
clinvar
1
clinvar
13
inframe indel
4
clinvar
1
clinvar
5
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
5
clinvar
9
clinvar
14
Total 16 10 36 15 17

Variants in FOXF1

This is a list of pathogenic ClinVar variants found in the FOXF1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
16-86510566-C-T FOXF1-related disorder Likely benign (Feb 25, 2020)3050972
16-86510568-C-T Alveolar capillary dysplasia with pulmonary venous misalignment Uncertain significance (Oct 26, 2018)1033844
16-86510585-G-C Inborn genetic diseases Uncertain significance (May 23, 2023)2549701
16-86510589-AG-A Alveolar capillary dysplasia with pulmonary venous misalignment Pathogenic (May 07, 2021)2500699
16-86510601-C-A Uncertain significance (Dec 03, 2022)2907581
16-86510604-ACGG-A Likely benign (Sep 01, 2023)2646946
16-86510604-ACGGCGG-A Uncertain significance (Oct 25, 2022)1949934
16-86510604-ACGGCGGCGG-A Uncertain significance (Aug 28, 2023)2068637
16-86510604-A-ACGG Alveolar capillary dysplasia with pulmonary venous misalignment • FOXF1-related disorder Conflicting classifications of pathogenicity (Jan 22, 2024)320786
16-86510607-G-T Inborn genetic diseases Uncertain significance (Jul 05, 2023)2609547
16-86510608-C-CGGCGGA Uncertain significance (Sep 27, 2022)1950436
16-86510615-G-A Inborn genetic diseases Uncertain significance (Dec 14, 2021)2266797
16-86510615-G-GGGCGGCGGCGGCGGGGGA Alveolar capillary dysplasia with pulmonary venous misalignment Uncertain significance (Mar 30, 2021)2500034
16-86510623-CGGCG-C Alveolar capillary dysplasia with pulmonary venous misalignment Pathogenic (-)973755
16-86510623-C-CG Pathogenic (Aug 04, 2020)1075487
16-86510625-G-GCCC Uncertain significance (Mar 10, 2023)2997252
16-86510626-CGGG-C Alveolar capillary dysplasia with pulmonary venous misalignment Conflicting classifications of pathogenicity (Jan 29, 2024)320787
16-86510639-G-A Inborn genetic diseases Uncertain significance (Dec 26, 2023)3096377
16-86510642-GC-G Pathogenic (Jan 19, 2018)988558
16-86510654-G-T Inborn genetic diseases Uncertain significance (Oct 03, 2023)3096378
16-86510658-C-A Alveolar capillary dysplasia with pulmonary venous misalignment Pathogenic (Oct 01, 2019)800366
16-86510659-G-C Likely benign (Jul 16, 2018)758200
16-86510664-G-A Inborn genetic diseases Uncertain significance (Dec 17, 2023)3096379
16-86510667-C-A Uncertain significance (Dec 02, 2021)1437741
16-86510667-C-T Inborn genetic diseases Uncertain significance (Sep 25, 2023)2965728

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
FOXF1protein_codingprotein_codingENST00000262426 23944
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.9580.042000000.00
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.091612050.7860.000009782406
Missense in Polyphen2663.5870.40889775
Synonymous-2.1511992.71.280.00000469764
Loss of Function2.9209.910.004.49e-7115

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000.00
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Probable transcription activator for a number of lung- specific genes.;
Disease
DISEASE: Alveolar capillary dysplasia with misalignment of pulmonary veins (ACDMPV) [MIM:265380]: A rare developmental disorder characterized by abnormal development of the capillary vascular system in the lungs. Histological features include failure of formation and ingrowth of alveolar capillaries, medial muscular thickening of small pulmonary arterioles with muscularization of the intraacinar arterioles, thickened alveolar walls, and anomalously situated pulmonary veins running alongside pulmonary arterioles and sharing the same adventitial sheath. Less common features include a reduced number of alveoli and a patchy distribution of the histopathologic changes. Affected infants present with respiratory distress and the disease is fatal within the newborn period. Additional features include multiple congenital anomalies affecting the cardiovascular, gastrointestinal, genitourinary, and musculoskeletal systems, as well as disruption of the normal right-left asymmetry of intrathoracic or intraabdominal organs. ACDMPV is a rare cause of persistent pulmonary hypertension of the newborn, an abnormal physiologic state caused by failure of transition of the pulmonary circulation from the high pulmonary vascular resistance of the fetus to the low pulmonary vascular resistance of the newborn. {ECO:0000269|PubMed:19500772, ECO:0000269|PubMed:23505205, ECO:0000269|PubMed:27145217}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
FOXA2 and FOXA3 transcription factor networks (Consensus)

Recessive Scores

pRec
0.203

Haploinsufficiency Scores

pHI
0.359
hipred
Y
hipred_score
0.837
ghis
0.479

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.849

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Foxf1
Phenotype
muscle phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); digestive/alimentary phenotype; embryo phenotype; respiratory system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan);

Zebrafish Information Network

Gene name
foxf1
Affected structure
vascular lymphangioblast
Phenotype tag
abnormal
Phenotype quality
absent

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;blood vessel development;vasculogenesis;in utero embryonic development;somitogenesis;morphogenesis of a branching structure;positive regulation of mesenchymal cell proliferation;endocardial cushion development;cardiac left ventricle morphogenesis;smoothened signaling pathway;determination of left/right symmetry;midgut development;heart development;positive regulation of cell-substrate adhesion;detection of wounding;extracellular matrix organization;respiratory tube development;lung development;positive regulation of cell migration;pancreas development;negative regulation of mast cell degranulation;establishment of epithelial cell apical/basal polarity;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;lung alveolus development;lateral mesodermal cell differentiation;embryonic digestive tract morphogenesis;digestive tract development;embryonic ectodermal digestive tract morphogenesis;embryonic foregut morphogenesis;negative regulation of inflammatory response;smooth muscle cell differentiation;regulation of smooth muscle cell differentiation;lung vasculature development;trachea development;epithelial tube branching involved in lung morphogenesis;right lung morphogenesis;lung lobe morphogenesis;venous blood vessel development;epithelial cell differentiation involved in mammary gland alveolus development;cellular response to cytokine stimulus;cellular response to organic cyclic compound;renal system development;ureter development;mesenchyme migration;ductus arteriosus closure;cell-cell adhesion
Cellular component
nucleus;transcription factor complex
Molecular function
RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;sequence-specific DNA binding